MNPR
USDMonopar Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$85.950
Máximo
$86.140
Mínimo
$80.105
Volume
0.14M
Fundamentos da empresa
Capitalização de mercado
510.3M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.07M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Barclays Initiates Coverage On Monopar Therapeutics with Overweight Rating, Announces Price Target of $125
Barclays analyst Etzer Darout initiates coverage on Monopar Therapeutics with a Overweight rating and announces Price Target of $125.
Raymond James Maintains Strong Buy on Monopar Therapeutics, Raises Price Target to $142
Raymond James analyst Chris Raymond maintains Monopar Therapeutics with a Strong Buy and raises the price target from $80 to $142.
HC Wainwright & Co. Maintains Buy on Monopar Therapeutics, Raises Price Target to $105
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Monopar Therapeutics with a Buy and raises the price target from $70 to $105.
Piper Sandler Maintains Overweight on Monopar Therapeutics, Raises Price Target to $95
Piper Sandler analyst Biren Amin maintains Monopar Therapeutics with a Overweight and raises the price target from $76 to $95.
Chardan Capital Maintains Buy on Monopar Therapeutics, Raises Price Target to $85
Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics with a Buy and raises the price target from $60 to $85.
BTIG Maintains Buy on Monopar Therapeutics, Raises Price Target to $104
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics with a Buy and raises the price target from $87 to $104.
Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
WILMETTE, Ill., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar Therapeutics", "Monopar", or the "Company"), a clinical-stage biopharmaceutical company developing innovative
Ações relacionadas
AVIR
Atea Pharmaceuticals Inc.
CMSD
CMS Energy Corporation 5.875% Junior Subordinated Notes due 2079
DAWN
Day One Biopharmaceuticals Inc.
CCD
Calamos Dynamic Convertible & Income Fund
TNXP
Tonix Pharmaceuticals Holding Corp.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.